Smith & Nephew competes with takeover target ArthroCare in arthroscopic devices
NYSE-listed Smith & Nephew competes with acquisition target ArthroCare in supplying medical devices to make surgery less painful and recovery faster. A spokesman for Smith & Nephew confirmed the $1.7 billion...To view the full article, register now.
Already a subscriber? Click here to view full article